Characteristics and Outcome of Coronavirus Disease 2019 (COVID-19) in Egypt
NCT04339322 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 200
Last updated 2020-04-09
Summary
The World Health Organization (WHO) has recently declared coronavirus disease 2019 (Covid-19) a public health emergency of international concern. Egypt is one of the countries that has been infected by Covid-19. The characteristics of clinical presentation, laboratory and radiological data are not yet studied. Outcomes of covid-19 in Egypt also have not been described yet.
Conditions
- Characteristics Diseases
- Outcome, Fatal
Interventions
- OTHER
-
Follow up
Follow up to assess the outcome until complications, improvement, death or being transferred to another quarantine hospital.
Sponsors & Collaborators
-
Assiut University
lead OTHER
Eligibility
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2020-05-01
- Primary Completion
- 2020-07-30
- Completion
- 2020-07-30
More Related Trials
-
Covid-19 Data Analyses in Brazil
NCT06652451 ·Status: COMPLETED
-
Worldwide Trends on COVID-19 Research After the Declaration of COVID-19 Pandemic
NCT04460547 ·Status: UNKNOWN
-
Parasitic Infection in Anemic Pregnant Women
NCT04391998 ·Status: UNKNOWN ·Phase: PHASE4
-
PRophylaxis of Exposed COVID-19 Individuals With Mild Symptoms Using choloroquinE Compounds
NCT04351191 ·Status: TERMINATED ·Phase: PHASE4
-
Efficacy of Pre-exposure Treatment With Hydroxy-Chloroquine on the Risk and Severity of COVID-19 Infection
NCT04481633 ·Status: COMPLETED ·Phase: NA
-
Evaluating the Efficacy of Artesunate in Adults With Mild Symptoms of COVID-19
NCT04387240 ·Status: WITHDRAWN ·Phase: PHASE2
-
Chloroquine Phosphate Prophylactic Use in Health Personnel Exposed to COVID-19 Patients
NCT04443270 ·Status: UNKNOWN ·Phase: PHASE1
-
An Observational Study to Assess the Protocol for the COVID-19 Treatment in Burkina Faso
NCT04445441 ·Status: COMPLETED
-
Post-Exposure Prophylaxis for Asymptomatic SARS-CoV-2 COVID-19 Patients With choloroquinE Compounds
NCT04346667 ·Status: TERMINATED ·Phase: PHASE4
-
Clinical Study Designed to Evaluate the Effect of CimetrA in Patients Diagnosed With COVID-19
NCT04802382 ·Status: UNKNOWN ·Phase: PHASE3
-
Add on to Azythromycine, Phytomedicine and/or Antimalarial Drug vs Hydroxychloroquine in Uncomplicated COVID-19 Patients
NCT04502342 ·Status: UNKNOWN ·Phase: PHASE2
-
Chloroquine Diphosphate in the Prevention of SARS in Covid-19 Infection
NCT04342650 ·Status: COMPLETED ·Phase: PHASE2
-
Chloroquine Diphosphate for the Treatment of Severe Acute Respiratory Syndrome Secondary to SARS-CoV2
NCT04323527 ·Status: COMPLETED ·Phase: PHASE2
-
The Effect of Chloroquine in the Treatment of Patients With Dengue
NCT00849602 ·Status: UNKNOWN ·Phase: PHASE1/PHASE2
-
Chloroquine as Antiviral Treatment in Coronavirus Infection 2020
NCT04331600 ·Status: COMPLETED ·Phase: PHASE4
-
Efficacy of Various Doses of Hydroxychloroquine in Pre-Exposure Prophylaxis for COVID 19
NCT04359537 ·Status: UNKNOWN ·Phase: PHASE2
-
Study of Biomarkers in the Long-term Impact of Coronavirus Infection in the Cardiorespiratory System
NCT04353245 ·Status: UNKNOWN
-
Safety and Efficacy of Hydroxychloroquine Associated With Azithromycin in SARS-Cov-2 Virus (COVID-19)
NCT04322123 ·Status: COMPLETED ·Phase: PHASE3
-
Effectiveness of Hydroxychloroquine in Covid-19 Patients
NCT04328272 ·Status: UNKNOWN ·Phase: PHASE3
-
Pharmacokinetic of Mefloquine-Artesunate in Plasmodium Falciparum Malaria Infection in Pregnancy
NCT00701961 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Monitoring Pregnant Women for Antimalarial Drug Resistance
NCT05072613 ·Status: COMPLETED
-
Hydroxychloroquine Azithromycin COVID-19 Pregnancy Trial
NCT04365231 ·Status: WITHDRAWN ·Phase: PHASE3
-
Hydroxychloroquine in Combination With Sirolimus and Dexamethasone for Treating COVID-19 Patients
NCT04374903 ·Status: WITHDRAWN ·Phase: NA
-
Long-term Use of Drugs That Could Prevent the Risk of Serious COVID-19 Infections or Make it Worse
NCT04356417 ·Status: UNKNOWN
-
Prevention With Chloroquine in Health Personnel Exposed to Infection With Coronavirus Disease 2019 (COVID-19) (TS-COVID)
NCT04627467 ·Status: COMPLETED ·Phase: PHASE2